Illumina's Board Recommends Stockholders Reject Roche Offer
Illumina (NASDAQ: ILMN) today is sending a letter from its Board of Directors highlighting supportive reports issued by two of the nation's leading proxy advisor firms. Illumina's Board recommends that stockholders reject Roche's offer and vote for the election of Illumina's highly qualified nominees at its 2012 Annual Meeting of Stockholders by completing the WHITE proxy card today
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.